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LACTOBACILLUS RHAMNOSUS GG MODULATES INTESTINAL BARRIER 
FUNCTION AND INFLAMMATION IN BALB/C MICE FOLLOWING DIETARY 
EXPOSURE TO DEOXYNIVALENOL AND ZEARALENONE THROUGH 
CHANGES IN GUT MICROBIOTA 
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Deoxynivalenol (DON) and zearalenone are mycotoxins produced by Fusarium species, 
which naturally co-occur in foods and feeds. The gastrointestinal tract represents the first 
barrier met by exogenous food/feed compounds. The purpose of the present study was to 
investigate the ability of Lactobacillus rhamnosus GG (LGG) to improve intestinal barrier 
functions and ameliorate inflammation in Balb/c mice (6 weeks old) fed diets containing 
mycotoxin mixtures (i.e. DON and ZEA) through modulation of intestinal bacterial 
compositions. An exposure regimen which stimulated the human exposure experience was 
designed. Two different protocols that vary the time-points of oral administration of LGG (1 x 
10
8
 CFU per day) were used to determine whether it could prevent and treat unwanted effects 
induced by DON (12 μg/g) and ZEA (0.5 μg/g). Chronic ingestion of DON and ZEA induced 
histological changes, reduced several tight junction protein gene expression such as claudin 
(Cldn)-1, Cldn-3, Cldn-4, Cldn-5, β-catenin (Ctnnb-1) and occludin (Ocln) in different 
intestinal segments accompanied by increases in plasma D-lactate and endotoxin levels. At 
the end of the experiment, plasma cytokine (TNF-α, IL-1β, IL-6, IFN-γ and IL-8) and serum 
immunoglobulin levels (IgA, IgG and IgM) were also assessed by ELISA and some of them 
were significantly up-regulated. Supplementation of LGG before and after DON and ZEA 
exposure in mice can improve, in certain extent, the intestinal barrier functions in mice 
following mycotoxin exposure, as shown by increased tight junction protein expression, 
improvement of the local intestinal immune function as well as inhibition of inflammatory 
responses in the intestine. These changes may be associated with changes in gut microbiota 
composition.
